Curative Ventures
Venture capitalDallas
Also known as CURATIVE VENTURES MANAGEMENT LLC
Investment thesis
Curative Ventures backs category-defining biotech companies working on novel therapies designed to dramatically improve patient outcomes. Acting as both a capital and talent partner, the firm supports companies advancing new treatments across areas such as oncology and other therapeutic domains. Its investment activity, evidenced by companies like Instil Bio, Peloton Therapeutics, Exonics, and TCR2 Therapeutics, spans developments through IPOs and acquisitions.
Source: firm website, verified Aug 7, 2026.
What they invest in
from 1 of 7 portfolio companiesBiotech Γ1
HQs:United StatesΓ2
Investments Β· 7 tracked
founders shown can be your intro pathInstil Bio is a biotechnology company that identifies and develops therapeutic opportunities, with a focus on cancer therapies.
BiotechDallas, US
Nimish Shah(Director)Bronson Crouch(Chief Executive Officer & Chairman of the Board)Jack Nielsen(Director)Gwen Binder(Director)Kent McGaughy(Director)Neil Gibson(Director)
San Francisco, US
Evan Sharp(Executive Officer)Mike Yang(Executive Officer)Benjamin Silbermann(Executive Officer, Director, Promoter)Natalie Fair(Executive Officer)
BoardJeremy Levine(Director)Jeff Jordan(Director)
Duchenne muscular dystrophy therapy developer acquired by Vertex.
Oncology company developing an oral HIF-2Ξ± inhibitor; acquired by Merck.
Cell therapy company that priced an IPO.
Frequently asked questions
- What sectors does Curative Ventures focus on?
- Curative Ventures focuses on Biotech.
- Where is Curative Ventures located?
- Curative Ventures is headquartered in Dallas, US.
Similar investors
8VC is a technology investment firm that builds and invests in ambitious companies across sectors including life sciences, healthcare, manufacturing, enterprise, logistics, and defense.
ACT Venture Capital is an independent Irish venture capital firm that invests β¬1 million to β¬15 million in growth-stage private companies, with capacity for larger commitments through syndicated rounds.
Amadeus Capital Partners is a UK-based deep tech venture capital firm founded in 1997 that invests from seed to growth stages across artificial intelligence, health, and sustainability-focused technologies.
Andreessen Horowitz's Strategic Partnerships page describes collaborations that connect its portfolio companies with established institutions to help scale and deploy their technology.
B Capital Group is a global venture capital firm that backs founders from early to late stage, with dedicated stage-based funds and a portfolio spanning technology, healthcare, and energy and resilience sectors.